Cargando…
A review of thiazolidinediones and metformin in the treatment of type 2 diabetes with focus on cardiovascular complications
The rising incidence of obesity and insulin resistance to epidemic proportions has closely paralleled the surge in the prevalence of diabetes and outpaced therapeutic advances in diabetes prevention and treatment. Current evidence points to obesity induced oxidative stress and chronic inflammation a...
Autores principales: | Behzad, Molavi, Negah, Rassouli, Suveer, Bagwe, Neda, Rasouli |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2350137/ https://www.ncbi.nlm.nih.gov/pubmed/18200815 |
Ejemplares similares
-
Treatment update: thiazolidinediones in combination with metformin for the treatment of type 2 diabetes
por: Stafford, John M, et al.
Publicado: (2007) -
The effect of metformin and thiazolidinedione use on lung cancer in diabetics
por: Mazzone, Peter J, et al.
Publicado: (2012) -
Review of the Case Reports on Metformin, Sulfonylurea, and Thiazolidinedione Therapies in Type 2 Diabetes Mellitus Patients
por: Susilawati, Elis, et al.
Publicado: (2023) -
Should metformin remain the first-line therapy for treatment of type 2 diabetes?
por: Baker, Chelsea, et al.
Publicado: (2021) -
Type 2 Diabetes: Uses of thiazolidinediones and insulin
por: T. Bloomgarden, Zachary
Publicado: (2011)